Cannara to Announce Fiscal Q2 2026 Financial Results on April 14, 2026

• Cannara Biotech announced it will release fiscal Q2 2026 financial results on April 14, 2026 at 7:00 AM ET.
• An earnings webcast featuring CEO Zohar Krivorot and CFO Nicholas Sosiak is scheduled for the same day at 10:00 AM ET with live Q&A; registration link provided.
• Haywood Securities initiated coverage of Cannara as of April 6, 2026 and issued a research report (details of rating or target price not disclosed in the release).
• The announcement provides no new operational or financial data beyond the schedule for the upcoming results.

• The news is primarily procedural: it merely sets the date for the quarterly earnings release, which investors already expect.
• Haywood’s coverage initiation adds an institutional analyst following, but without a disclosed recommendation or price target its immediate material effect is uncertain and likely incremental.
• No surprise financial beats/misses, guidance changes, or strategic transactions are reported.
• Consequently, the announcement is expected to have minimal impact on the share price unless the forthcoming Q2 results deviate significantly from market expectations.

• Cannara Biotech operates two large cultivation facilities in Quebec (> 1.6 million sq ft) with up to 100,000 kg annual production capacity.
• Flagship project: the Valleyfield processing centre, currently on budget for completion by fiscal year‑end 2026; once operational it will add processing capacity and enable three additional grow zones slated for activation at the start of FY2027.